Modifiable risk factors and inflammation-related proteins in polymyalgia rheumatica: genome-wide meta-analysis and Mendelian randomisation
View ORCID ProfileSizheng Steven Zhao, Sarah L Mackie, View ORCID ProfileSusanna C Larsson, View ORCID ProfileStephen Burgess, View ORCID ProfileShuai Yuan
doi: https://doi.org/10.1101/2024.04.21.24306135
Sizheng Steven Zhao
1Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Science, School of Biological Sciences, Faculty of Biological Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
Sarah L Mackie
2Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK
3National Institute for Health Research Leeds Biomedical Research Centre, Leeds Teaching Hospitals, University of Leeds, Leeds, UK
Susanna C Larsson
4Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Nobelsväg 13, 17177, Stockholm, Sweden
5Department of Surgical Sciences, Uppsala University, Dag Hammarskjölds Väg 14B, 75185, Uppsala, Sweden
Stephen Burgess
6British Heart Foundation Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK
7Heart and Lung Research Institute, University of Cambridge, Cambridge UK
8Medical Research Council Biostatistics Unit, University of Cambridge, Cambridge, UK
Shuai Yuan
4Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Nobelsväg 13, 17177, Stockholm, Sweden
Posted April 22, 2024.
Modifiable risk factors and inflammation-related proteins in polymyalgia rheumatica: genome-wide meta-analysis and Mendelian randomisation
Sizheng Steven Zhao, Sarah L Mackie, Susanna C Larsson, Stephen Burgess, Shuai Yuan
medRxiv 2024.04.21.24306135; doi: https://doi.org/10.1101/2024.04.21.24306135
Modifiable risk factors and inflammation-related proteins in polymyalgia rheumatica: genome-wide meta-analysis and Mendelian randomisation
Sizheng Steven Zhao, Sarah L Mackie, Susanna C Larsson, Stephen Burgess, Shuai Yuan
medRxiv 2024.04.21.24306135; doi: https://doi.org/10.1101/2024.04.21.24306135
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2939)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12743)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4582)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4350)
- Nursing (236)
- Nutrition (639)
- Oncology (2268)
- Ophthalmology (646)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6935)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (488)
- Toxicology (60)
- Transplantation (212)
- Urology (180)